Peter Paras Jr.

Array ( [id] => 1388636 [patent_doc_number] => 06544781 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Non-defective Epstein-Barr viral vector' [patent_app_type] => B1 [patent_app_number] => 09/617800 [patent_app_country] => US [patent_app_date] => 2000-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 9684 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544781.pdf [firstpage_image] =>[orig_patent_app_number] => 09617800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1247511 [patent_doc_number] => 06673340 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Basement membrane degrading proteases as insect toxins and methods of use for same' [patent_app_type] => B1 [patent_app_number] => 09/614789 [patent_app_country] => US [patent_app_date] => 2000-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16113 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673340.pdf [firstpage_image] =>[orig_patent_app_number] => 09614789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1377878 [patent_doc_number] => 06555367 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-29 [patent_title] => 'Complex of biotinylated viral vector and ligand for targeted gene delivery' [patent_app_type] => B1 [patent_app_number] => 09/509698 [patent_app_country] => US [patent_app_date] => 2000-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 7229 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555367.pdf [firstpage_image] =>[orig_patent_app_number] => 09509698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1092660 [patent_doc_number] => 06825028 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-30 [patent_title] => 'Recombinant listeria' [patent_app_type] => B1 [patent_app_number] => 09/581005 [patent_app_country] => US [patent_app_date] => 2000-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12508 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825028.pdf [firstpage_image] =>[orig_patent_app_number] => 09581005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1273306 [patent_doc_number] => 06649377 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-18 [patent_title] => 'Human aggrecanase and nucleic acid compositions encoding the same' [patent_app_type] => B1 [patent_app_number] => 09/568559 [patent_app_country] => US [patent_app_date] => 2000-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14148 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649377.pdf [firstpage_image] =>[orig_patent_app_number] => 09568559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1145568 [patent_doc_number] => 06773893 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-10 [patent_title] => 'Human ABC1 promoter and assays based thereon' [patent_app_type] => B1 [patent_app_number] => 09/560372 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 10567 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/773/06773893.pdf [firstpage_image] =>[orig_patent_app_number] => 09560372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7632893 [patent_doc_number] => 06664441 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Compound assay' [patent_app_type] => B1 [patent_app_number] => 09/549411 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6510 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664441.pdf [firstpage_image] =>[orig_patent_app_number] => 09549411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093631 [patent_doc_number] => 06825395 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-30 [patent_title] => 'Transgenic non-human mammals expressing the human complement inhibitor (DAF/CD55)' [patent_app_type] => B1 [patent_app_number] => 09/462740 [patent_app_country] => US [patent_app_date] => 2000-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5759 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825395.pdf [firstpage_image] =>[orig_patent_app_number] => 09462740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408726 [patent_doc_number] => 06239117 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Gene therapy for regulating bladder smooth muscle tone' [patent_app_type] => 1 [patent_app_number] => 9/531968 [patent_app_country] => US [patent_app_date] => 2000-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 33 [patent_no_of_words] => 23134 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239117.pdf [firstpage_image] =>[orig_patent_app_number] => 531968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406279 [patent_doc_number] => 06271211 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Gene therapy for regulating penile smooth muscle tone' [patent_app_type] => 1 [patent_app_number] => 9/532138 [patent_app_country] => US [patent_app_date] => 2000-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 33 [patent_no_of_words] => 23343 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271211.pdf [firstpage_image] =>[orig_patent_app_number] => 532138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420185 [patent_doc_number] => 06509514 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-21 [patent_title] => 'Chimeric animal model susceptible to human hepatitis C virus infection' [patent_app_type] => B1 [patent_app_number] => 09/528120 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 11383 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/509/06509514.pdf [firstpage_image] =>[orig_patent_app_number] => 09528120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409180 [patent_doc_number] => 06271435 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Leukotriene B4 receptor transgenic mice' [patent_app_type] => 1 [patent_app_number] => 9/524302 [patent_app_country] => US [patent_app_date] => 2000-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 7904 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271435.pdf [firstpage_image] =>[orig_patent_app_number] => 524302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1265871 [patent_doc_number] => 06660906 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'Tpl2 transgenic knockout mice' [patent_app_type] => B1 [patent_app_number] => 09/522775 [patent_app_country] => US [patent_app_date] => 2000-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 34 [patent_no_of_words] => 22952 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660906.pdf [firstpage_image] =>[orig_patent_app_number] => 09522775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1393247 [patent_doc_number] => 06548740 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Methods for creating transgenic animals' [patent_app_type] => B1 [patent_app_number] => 09/502264 [patent_app_country] => US [patent_app_date] => 2000-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18944 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548740.pdf [firstpage_image] =>[orig_patent_app_number] => 09502264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636285 [patent_doc_number] => 06380374 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Human intestinal Npt2B' [patent_app_type] => B1 [patent_app_number] => 09/499964 [patent_app_country] => US [patent_app_date] => 2000-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13454 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380374.pdf [firstpage_image] =>[orig_patent_app_number] => 09499964 [rel_patent_id] =>[rel_patent_doc_number] =>)